When: Confirmed daily close above $475 200 SMA with positive MACD divergence OR retest and hold of $332 with bullish momentum signals

Then: Wait for either condition before initiating new long positions

SELL current entry; WAIT for $345 retest with capitulation volume (stop $310) or reclaim of $389 with confirmed close above (stop $355)

• MACD histogram at 2.05 signals momentum fading, not compression in selling pressure as aggressive claims
• August 20 was a bearish outside reversal: opened 397, hit 399, closed 374 on 3.97M shares—a 5.8% intraday reversal on elevated volume
• RSI divergence: 59.71 in early July versus 59.63 in mid-August when price made a higher high
• Realistic growth assumption is 15-18% (not 25%), yielding PEG of 1.7-2.0; ISRG has never sustained 25% annual revenue growth
• Working capital red flags: receivables up 27.3%, inventory up 21.7% versus revenue up 18.5%; $1.4B consumed over four quarters
• ISRG down 17.5% over six months due to macro factors, not company-specific issues; Polymarket prices 86% odds of no Fed cuts in 2026
• Institutional accumulation argument unsupported: one Oppenheimer upgrade and one TCW letter are not evidence of sustained accumulation
• $332 level is untested and could break under sustained macro pressure, not a hard floor
• Current position sizing of 2-2.5% with $325 stop represents 33-52 basis points of portfolio at risk with 1.46 beta
• Framing 'disciplined aggression' as conservative entry is misleading; waiting for better setup is the actual conservative position

→ vs aggressive: Technical analysis is cherry-picked: MACD histogram at 2.05 is momentum fading, not compression; August 20 bearish outside reversal on 3.97M shares volume is ignored

→ vs aggressive: RSI lower highs do matter: 59.71 in July versus 59.63 in August during higher price is textbook bearish divergence

→ vs aggressive: Valuation math already concedes bear case by using 25% growth; realistic 15-18% yields PEG of 1.7-2.0

→ vs aggressive: Working capital dismissal is weak: $1.4B consumed over four quarters with receivables up 27.3% and inventory up 21.7% is a pattern, not timing

→ vs aggressive: Opportunity cost argument is dangerous: stock is macro-driven (86% odds of no Fed cuts in 2026), not company-specific

→ vs aggressive: Institutional accumulation claim is unsubstantiated: Oppenheimer upgrade and TCW letter are opinion pieces, not 13F data or sustained volume accumulation

→ vs aggressive: $325 stop treats a single untested swing low at $332 as a hard floor when it could break under macro pressure

→ vs neutral: Entry zone of $326-$362 is being framed as 'missing the trade' when the conservative view is the trade is not yet available

SELL

• Reduce initial tranche to 33-40% of target weight (0.7-1.0% of portfolio at risk) and only execute if price retraces to $355-$365 range over next 1-2 weeks
• Alternative: cap initial tranche at 40% if acting now (0.8-1.0% of portfolio at risk) with stop at $325
• Maintain $325 stop (13% buffer against current entry, structural level)
• Keep total position cap at 3-4% of portfolio (appropriate for 1.46 beta)
• Active position at risk should be 1/3 of total, not 3/4; reserve majority of dry powder
• MACD histogram printing lower highs on every session since August 13 - distribution signature
• August 20 was 5.8% intraday reversal on nearly 4 million shares volume
• Stock down 17.5% over six months with wide trading range, not new lows = accumulation
• Valuation overstated by ~30%: realistic PEG is 1.7-2.0 at 15-18% growth (vs 25% assumption giving PEG under 1.25)
• Balance sheet strong with $8.6 billion cash, zero material debt, 4.96 current ratio
• $332 swing low held since July 23 - structural floor
• Path to $474 requires three aligned conditions: yields rolling over, 50 SMA reclaimed on volume, continued institutional accumulation
• Polymarket pricing 86% odds of no Fed cuts in 2026
• Working capital deterioration in context of expanding gross margins, operating margins, and FCF likely timing issue not structural credit problem

→ vs aggressive: MACD analysis is wrong—lower highs since August 13 and 5.8% reversal on 4M shares volume is fresh distribution, not accumulation

→ vs aggressive: Valuation overstated by ~30%—ISRG has never sustained 25% growth; realistic PEG is 1.7-2.0 at 15-18% growth

→ vs aggressive: Ignoring macro headwind—Polymarket pricing 86% odds of no Fed cuts in 2026, long-duration growth being sold; $345 retest possible regardless of franchise quality

→ vs conservative: $332 swing low has held since July 23—structural floor dismissed too casually

→ vs conservative: Working capital deterioration likely timing on collections given expanding margins and FCF, not structural credit issue

→ vs conservative: Entry framework too rigid—ignoring consolidation zone $355-$365 where better risk/reward exists vs capitulation or breakout scenarios